{4-[(4-Chloro-phenyl)-phenyl-methoxy]-butyl}-(4-methoxy-benzyl)-amine

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: {4-[(4-Chloro-phenyl)-phenyl-methoxy]-butyl}-(4-methoxy-benzyl)-amine
• 英文别名: 4-[(4-chlorophenyl)-phenylmethoxy]-N-[(4-methoxyphenyl)methyl]butan-1-amine
• 化学式: C₂₅H₂₈ClNO₂
• 分子量: 409.956
• InChiKey: BETKKUYBEQYZRS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.6
• 重原子数：
  29
• 可旋转键数：
  11
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  30.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  4-(4-methoxybenzylamino)butan-1-ol 、 4-氯二苯甲醇 在 对甲苯磺酸 作用下， 以 甲苯 为溶剂， 反应 6.0h， 以83%的产率得到{4-[(4-Chloro-phenyl)-phenyl-methoxy]-butyl}-(4-methoxy-benzyl)-amine
  参考文献：
  名称：

  研究新型的浓度依赖性，双重作用的T型钙通道激动剂/拮抗剂的构效关系。

  摘要：

  本文描述了先前在我们的研究程序中合成的化合物（1）的一系列直链类似物的合成和生物学评估。这些化合物是T型钙通道拮抗剂，对多种癌细胞表现出有效的抗增殖活性。这些类似物与多种癌细胞的构效关系为深入研究该系列化合物的合理药效团提供了见解。此外，这一系列化合物已将自己呈现为一组针对T型钙通道的新型，浓度依赖性，双重作用的激动剂/拮抗剂。

  DOI：

  10.1016/j.bmc.2005.03.004

文献信息

• T type calcium channel inhibitors
  申请人：University of Virginia Patent Foundation

  公开号：US10369120B2

  公开（公告）日：2019-08-06

  The present invention provides novel T type calcium channel inhibitors of formula (I), the use thereof in the treatment of a disease or condition in a mammal associated with influx of extracellular calcium via T type calcium channels, wherein R1 is C1-C4 alkyl, hydroxy, or C1-C4 alkoxy; Z is NH, NCH3, O, S, or CH2; Y is NH, O, or CH2 with the proviso that Y and Z are not the same; R2 is H, halo, NH2, C1-C4 alkyl, hydroxy, or C1-C4 alkoxy; m and n are independently selected from integers ranging from 1-5 with the proviso that m+n=an integer ranging from 2-9; and R3 is H, halo, NH2, C1-C4 alkyl, hydroxy, or C1-C4 alkoxy.

  本发明提供了式(I)的新型T型钙通道抑制剂，其用途是治疗哺乳动物体内与细胞外钙通过T型钙通道流入有关的疾病或病症，其中R1是C1-C4烷基、羟基或C1-C4烷氧基；Z是NH、NCH3、O、S或CH2；Y是NH、O或CH2，但Y和Z不相同；R2是H、卤素、NH2、C1-C4烷基、羟基或C1-C4烷氧基；m和n独立地选自1-5的整数，但m+n=2-9的整数；以及R3是H、卤素、NH2、C1-C4烷基、羟基或C1-C4烷氧基。
• T Type Calcium Channel Inhibitors
  申请人：Gray Lloyd S.

  公开号：US20090234019A1

  公开（公告）日：2009-09-17

  The present invention provides novel T type calcium channel inhibitors of formula (I), the use thereof in the treatment of a disease or condition in a mammal associated with influx of extracellular calcium via T type calcium channels, wherein R 1 is C 1 -C 4 alkyl, hydroxy, or C 1 -C 4 alkoxy; Z is NH, NCH 3 , O, S, or CH 2 ; Y is NH, O, or CH 2 with the proviso that Y and Z are not the same; R 2 is H, halo, NH 2 , C 1 -C 4 alkyl, hydroxy, or C 1 -C 4 alkoxy; m and n are independently selected from integers ranging from 1-5 with the proviso that m+n=an integer ranging from 2-9; and R 3 is H, halo, NH 2 , C 1 -C 4 alkyl, hydroxy, or C 1 -C 4 alkoxy.
• T TYPE CALCIUM CHANNEL INHIBITORS
  申请人：University of Virginia Patent Foundation

  公开号：US20160136115A1

  公开（公告）日：2016-05-19

  The present invention provides novel T type calcium channel inhibitors of formula (I), the use thereof in the treatment of a disease or condition in a mammal associated with influx of extracellular calcium via T type calcium channels, wherein R 1 is C 1 -C 4 alkyl, hydroxy, or C 1 -C 4 alkoxy; Z is NH, NCH 3 , O, S, or CH 2 ; Y is NH, O, or CH 2 with the proviso that Y and Z are not the same; R 2 is H, halo, NH 2 , C 1 -C 4 alkyl, hydroxy, or C 1 -C 4 alkoxy; m and n are independently selected from integers ranging from 1-5 with the proviso that m+n=an integer ranging from 2-9; and R 3 is H, halo, NH 2 , C 1 -C 4 alkyl, hydroxy, or C 1 -C 4 alkoxy.
• US9212127B2
  申请人：——

  公开号：US9212127B2

  公开（公告）日：2015-12-15
• [EN] T TYPE CALCIUM CHANNEL INHIBITORS<br/>[FR] INHIBITEURS DE CANAL CALCIUM DE TYPE T
  申请人：UNIV VIRGINIA

  公开号：WO2006023883A2

  公开（公告）日：2006-03-02

  The present invention provides novel T type calcium channel inhibitors of formula (I), the use thereof in the treatment of a disease or condition in a mammal associated with influx of extracellular calcium via T type calcium channels, wherein R1 is C1-C4 alkyl, hydroxy, or C1-C4 alkoxy; Z is NH, NCH3, O, S, or CH2; Y is NH, O, or CH2 with the proviso that Y and Z are not the same; R2 is H, halo, NH2, C1-C4 alkyl, hydroxy, or C1-C4 alkoxy; m and n are independently selected from integers ranging from 1-5 with the proviso that m + n = an integer ranging from 2-9; and R3 is H, halo, NH2, C1-C4 alkyl, hydroxy, or C1-C4 alkoxy.